1h Free Analyst Time
The orthobiologics market is forecasted to grow by USD 2.76 billion during 2023-2028, accelerating at a CAGR of 7.75% during the forecast period. The report on the orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of orthopedic disorders coupled with an aging population, increase in focus to reduce orthopedic surgeries, and rise in approvals and clearances for orthobiologics products.
The orthobiologics market is segmented as below:
By Application
- Spinal fusion
- Reconstructive surgery
- Trauma repair
- Others
By Product
- Bone graft substitutes
- Viscosupplementation
- Stem cells
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the orthobiologics market covers the following areas:
- Orthobiologics market sizing
- Orthobiologics market forecast
- Orthobiologics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global orthobiologics market: Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Institut Straumann AG, Integra Lifesciences Corp., Johnson and Johnson Services Inc., Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc., Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in development of new products."
According to the report, one of the major drivers for this market is the increasing prevalence of orthopedic disorders coupled with an aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group Plc
- Anika Therapeutics Inc.
- Arthrex Inc.
- Bioventus LLC
- Globus Medical Inc.
- Institut Straumann AG
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- Kuros Biosciences AG
- Medtronic Plc
- MTF Biologics
- Nuvasive Inc.
- Orthofix Medical Inc.
- OrthoPediatrics Corp.
- ROYAL BIOLOGICS
- RTI Surgical Inc.
- Smith and Nephew plc
- Stryker Corp.
- Xtant Medical Holdings Inc.
- Zimmer Biomet Holdings Inc.
